CRP and prostate carcinoma: A meta-analysis of five prospective cohort studies reported that circulating CRP levels were not associated with risk of prostate cancer (OR 1.06, 95% CI 0.97 to 1.16, and P = 0.83) (25), which was in line with findings from the present study.